Dheeraj Jain

Dheeraj Jain is the founder and managing partner of Redcliffe Capital and Redcliffe Group (Redcliffe Labs and adjacent ventures), an active India-focused operator-angel. His health pattern is diagnostics, biotech, and women’s and reproductive health at pre-seed and seed, with AI focus flagged. $25k-$100k checks. Delhi-based, India scope. Best fit: India-based founders in diagnostics, women’s health, and biotech-adjacent areas, particularly anyone whose product complements or competes thoughtfully with the Redcliffe Labs ecosystem (diagnostics, fertility, genetics) and who would benefit from a strategic operator on the cap table; founders comfortable with a check that may come with strong opinions about commercial strategy in India. Entry path is LinkedIn or Twitter (publicly active), or warm intros through the Redcliffe portfolio and Delhi healthcare network. Not a fit for US-payer digital health, devices outside the Indian context, or pure consumer wellness. Expect detailed commercial questions on Indian distribution, lab economics, and unit-cost reality; expect less depth on US regulatory pathways. For an Indian diagnostics or women’s health founder, this is one of the more domain-aligned early checks available; for non-Indian founders, this is the wrong door.